真核生物発現システム世界市場の発展状況と動向 2024-2030
英文タイトル: Global Eukaryotic Expression Systems Market Insights, Forecast to 2030
販売価格(消費税別)
個人版
マルチユーザー版
企業版
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
概要
本報告書は真核生物発現システム市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは真核生物発現システムの主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。
世界の真核生物発現システム市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは真核生物発現システムのメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に真核生物発現システム市場を分類しています。本研究に含まれる主な企業は:Thermo Fisher、Sigma Aldrich、Jena Bioscience、New England Biolabs、Takara Bio、Bio Rad、Promega、Agilent、Merck Millipore
地域別市場区分、地域別分析は以下の通り:
アメリカとカナダ
中国
アジア
ヨーロッパ
中東、アフリカ、ラテンアメリカ
タイプ別市場セグメント:
Reagents
Expression vectors
Competent cells
用途別の市場セグメント:
Bacterial Expression System
Yeast Expression System
Insect Expression System
Mammalian Expression System
本レポートの詳細内容
世界の真核生物発現システム市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、真核生物発現システムタイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の真核生物発現システム収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の真核生物発現システム市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、真核生物発現システム市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。
真核生物発現システムのレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。
章の概要
第1章:真核生物発現システムのレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント(製品タイプ、用途など)のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。(2019~2030)
第2章:真核生物発現システムの世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。(2019~2030)
第3章真核生物発現システム企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。(2019~2030)
第4章:各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(2019~2024)
第5章:真核生物発現システムの各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。(2019~2030)
第6章:北米(米国、カナダ)のタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第7章:ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第8章:中国の種類別、および用途別、各セグメントの収益。(2019~2030)
第9章アジア(中国を除く)の種類別、用途別、地域別、セグメントごとの収益。(2019~2030)
第10章:中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第11章:真核生物発現システムの主要企業の概要を提供し、製品の説明と仕様、真核生物発現システムの収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。(2019~2024)
第12章:アナリストの見解/結論
概要
Market Analysis and Insights: Global Eukaryotic Expression Systems Market The global Eukaryotic Expression Systems market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Eukaryotic Expression Systems is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030. The China market for Eukaryotic Expression Systems is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030. The Europe market for Eukaryotic Expression Systems is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030. The global key companies of Eukaryotic Expression Systems include Thermo Fisher, Sigma Aldrich, Jena Bioscience, New England Biolabs, Takara Bio, Bio Rad, Promega, Agilent and Merck Millipore, etc. In 2023, the global top five players had a share approximately % in terms of revenue. Eukaryotic Expression Systems is widely used in various fields, such as Bacterial Expression System, Yeast Expression System, Insect Expression System and Mammalian Expression System, etc. Bacterial Expression System provides greatest supports to the Eukaryotic Expression Systems industry development. In 2023, global % revenue of Eukaryotic Expression Systems went into Bacterial Expression System filed and the proportion will reach to % in 2030. Report Covers: This report presents an overview of global market for Eukaryotic Expression Systems market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. This report researches the key producers of Eukaryotic Expression Systems, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Eukaryotic Expression Systems, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries. This report focuses on the Eukaryotic Expression Systems revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Eukaryotic Expression Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Eukaryotic Expression Systems revenue, projected growth trends, production technology, application and end-user industry. Descriptive company profiles of the major global players, including Thermo Fisher, Sigma Aldrich, Jena Bioscience, New England Biolabs, Takara Bio, Bio Rad, Promega, Agilent and Merck Millipore, etc. Market Segmentation By Company Thermo Fisher Sigma Aldrich Jena Bioscience New England Biolabs Takara Bio Bio Rad Promega Agilent Merck Millipore Segment by Type Reagents Expression vectors Competent cells Segment by Application Bacterial Expression System Yeast Expression System Insect Expression System Mammalian Expression System By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe China Asia (excluding China) Japan South Korea China Taiwan Southeast Asia India Latin America, Middle East & Africa Brazil Mexico Turkey Israel GCC Countries Chapter Outline Chapter Outline Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 2: Revenue of Eukaryotic Expression Systems in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 3: Detailed analysis of Eukaryotic Expression Systems companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment. Chapter 7: Europe by Type, by Application and by country, revenue for each segment. Chapter 8: China by Type, and by Application, revenue for each segment. Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment. Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment. Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Eukaryotic Expression Systems revenue, gross margin, and recent development, etc. Chapter 12: Analyst's Viewpoints/Conclusions
総目録
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Eukaryotic Expression Systems Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Reagents
1.2.3 Expression vectors
1.2.4 Competent cells
1.3 Market by Application
1.3.1 Global Eukaryotic Expression Systems Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Bacterial Expression System
1.3.3 Yeast Expression System
1.3.4 Insect Expression System
1.3.5 Mammalian Expression System
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Eukaryotic Expression Systems Market Perspective (2019-2030)
2.2 Global Eukaryotic Expression Systems Growth Trends by Region
2.2.1 Eukaryotic Expression Systems Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Eukaryotic Expression Systems Historic Market Size by Region (2019-2024)
2.2.3 Eukaryotic Expression Systems Forecasted Market Size by Region (2025-2030)
2.3 Eukaryotic Expression Systems Market Dynamics
2.3.1 Eukaryotic Expression Systems Industry Trends
2.3.2 Eukaryotic Expression Systems Market Drivers
2.3.3 Eukaryotic Expression Systems Market Challenges
2.3.4 Eukaryotic Expression Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Eukaryotic Expression Systems by Players
3.1.1 Global Eukaryotic Expression Systems Revenue by Players (2019-2024)
3.1.2 Global Eukaryotic Expression Systems Revenue Market Share by Players (2019-2024)
3.2 Global Eukaryotic Expression Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Eukaryotic Expression Systems, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Eukaryotic Expression Systems Market Concentration Ratio
3.4.1 Global Eukaryotic Expression Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Eukaryotic Expression Systems Revenue in 2023
3.5 Global Key Players of Eukaryotic Expression Systems Head office and Area Served
3.6 Global Key Players of Eukaryotic Expression Systems, Product and Application
3.7 Global Key Players of Eukaryotic Expression Systems, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Eukaryotic Expression Systems Breakdown Data by Type
4.1 Global Eukaryotic Expression Systems Historic Market Size by Type (2019-2024)
4.2 Global Eukaryotic Expression Systems Forecasted Market Size by Type (2025-2030)
5 Eukaryotic Expression Systems Breakdown Data by Application
5.1 Global Eukaryotic Expression Systems Historic Market Size by Application (2019-2024)
5.2 Global Eukaryotic Expression Systems Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Eukaryotic Expression Systems Market Size (2019-2030)
6.2 North America Eukaryotic Expression Systems Market Size by Type
6.2.1 North America Eukaryotic Expression Systems Market Size by Type (2019-2024)
6.2.2 North America Eukaryotic Expression Systems Market Size by Type (2025-2030)
6.2.3 North America Eukaryotic Expression Systems Market Share by Type (2019-2030)
6.3 North America Eukaryotic Expression Systems Market Size by Application
6.3.1 North America Eukaryotic Expression Systems Market Size by Application (2019-2024)
6.3.2 North America Eukaryotic Expression Systems Market Size by Application (2025-2030)
6.3.3 North America Eukaryotic Expression Systems Market Share by Application (2019-2030)
6.4 North America Eukaryotic Expression Systems Market Size by Country
6.4.1 North America Eukaryotic Expression Systems Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Eukaryotic Expression Systems Market Size by Country (2019-2024)
6.4.3 North America Eukaryotic Expression Systems Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Eukaryotic Expression Systems Market Size (2019-2030)
7.2 Europe Eukaryotic Expression Systems Market Size by Type
7.2.1 Europe Eukaryotic Expression Systems Market Size by Type (2019-2024)
7.2.2 Europe Eukaryotic Expression Systems Market Size by Type (2025-2030)
7.2.3 Europe Eukaryotic Expression Systems Market Share by Type (2019-2030)
7.3 Europe Eukaryotic Expression Systems Market Size by Application
7.3.1 Europe Eukaryotic Expression Systems Market Size by Application (2019-2024)
7.3.2 Europe Eukaryotic Expression Systems Market Size by Application (2025-2030)
7.3.3 Europe Eukaryotic Expression Systems Market Share by Application (2019-2030)
7.4 Europe Eukaryotic Expression Systems Market Size by Country
7.4.1 Europe Eukaryotic Expression Systems Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Eukaryotic Expression Systems Market Size by Country (2019-2024)
7.4.3 Europe Eukaryotic Expression Systems Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Eukaryotic Expression Systems Market Size (2019-2030)
8.2 China Eukaryotic Expression Systems Market Size by Type
8.2.1 China Eukaryotic Expression Systems Market Size by Type (2019-2024)
8.2.2 China Eukaryotic Expression Systems Market Size by Type (2025-2030)
8.2.3 China Eukaryotic Expression Systems Market Share by Type (2019-2030)
8.3 China Eukaryotic Expression Systems Market Size by Application
8.3.1 China Eukaryotic Expression Systems Market Size by Application (2019-2024)
8.3.2 China Eukaryotic Expression Systems Market Size by Application (2025-2030)
8.3.3 China Eukaryotic Expression Systems Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Eukaryotic Expression Systems Market Size (2019-2030)
9.2 Asia Eukaryotic Expression Systems Market Size by Type
9.2.1 Asia Eukaryotic Expression Systems Market Size by Type (2019-2024)
9.2.2 Asia Eukaryotic Expression Systems Market Size by Type (2025-2030)
9.2.3 Asia Eukaryotic Expression Systems Market Share by Type (2019-2030)
9.3 Asia Eukaryotic Expression Systems Market Size by Application
9.3.1 Asia Eukaryotic Expression Systems Market Size by Application (2019-2024)
9.3.2 Asia Eukaryotic Expression Systems Market Size by Application (2025-2030)
9.3.3 Asia Eukaryotic Expression Systems Market Share by Application (2019-2030)
9.4 Asia Eukaryotic Expression Systems Market Size by Region
9.4.1 Asia Eukaryotic Expression Systems Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Eukaryotic Expression Systems Market Size by Region (2019-2024)
9.4.3 Asia Eukaryotic Expression Systems Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Size by Type
10.2.1 Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Size by Application
10.3.1 Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Size by Country
10.4.1 Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Details
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Eukaryotic Expression Systems Introduction
11.1.4 Thermo Fisher Revenue in Eukaryotic Expression Systems Business (2019-2024)
11.1.5 Thermo Fisher Recent Developments
11.2 Sigma Aldrich
11.2.1 Sigma Aldrich Company Details
11.2.2 Sigma Aldrich Business Overview
11.2.3 Sigma Aldrich Eukaryotic Expression Systems Introduction
11.2.4 Sigma Aldrich Revenue in Eukaryotic Expression Systems Business (2019-2024)
11.2.5 Sigma Aldrich Recent Developments
11.3 Jena Bioscience
11.3.1 Jena Bioscience Company Details
11.3.2 Jena Bioscience Business Overview
11.3.3 Jena Bioscience Eukaryotic Expression Systems Introduction
11.3.4 Jena Bioscience Revenue in Eukaryotic Expression Systems Business (2019-2024)
11.3.5 Jena Bioscience Recent Developments
11.4 New England Biolabs
11.4.1 New England Biolabs Company Details
11.4.2 New England Biolabs Business Overview
11.4.3 New England Biolabs Eukaryotic Expression Systems Introduction
11.4.4 New England Biolabs Revenue in Eukaryotic Expression Systems Business (2019-2024)
11.4.5 New England Biolabs Recent Developments
11.5 Takara Bio
11.5.1 Takara Bio Company Details
11.5.2 Takara Bio Business Overview
11.5.3 Takara Bio Eukaryotic Expression Systems Introduction
11.5.4 Takara Bio Revenue in Eukaryotic Expression Systems Business (2019-2024)
11.5.5 Takara Bio Recent Developments
11.6 Bio Rad
11.6.1 Bio Rad Company Details
11.6.2 Bio Rad Business Overview
11.6.3 Bio Rad Eukaryotic Expression Systems Introduction
11.6.4 Bio Rad Revenue in Eukaryotic Expression Systems Business (2019-2024)
11.6.5 Bio Rad Recent Developments
11.7 Promega
11.7.1 Promega Company Details
11.7.2 Promega Business Overview
11.7.3 Promega Eukaryotic Expression Systems Introduction
11.7.4 Promega Revenue in Eukaryotic Expression Systems Business (2019-2024)
11.7.5 Promega Recent Developments
11.8 Agilent
11.8.1 Agilent Company Details
11.8.2 Agilent Business Overview
11.8.3 Agilent Eukaryotic Expression Systems Introduction
11.8.4 Agilent Revenue in Eukaryotic Expression Systems Business (2019-2024)
11.8.5 Agilent Recent Developments
11.9 Merck Millipore
11.9.1 Merck Millipore Company Details
11.9.2 Merck Millipore Business Overview
11.9.3 Merck Millipore Eukaryotic Expression Systems Introduction
11.9.4 Merck Millipore Revenue in Eukaryotic Expression Systems Business (2019-2024)
11.9.5 Merck Millipore Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
表と図のリスト
List of Tables Table 1. Global Eukaryotic Expression Systems Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030 Table 2. Key Players of Reagents Table 3. Key Players of Expression vectors Table 4. Key Players of Competent cells Table 5. Global Eukaryotic Expression Systems Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030 Table 6. Global Eukaryotic Expression Systems Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 7. Global Eukaryotic Expression Systems Market Size by Region (2019-2024) & (US$ Million) Table 8. Global Eukaryotic Expression Systems Market Share by Region (2019-2024) Table 9. Global Eukaryotic Expression Systems Forecasted Market Size by Region (2025-2030) & (US$ Million) Table 10. Global Eukaryotic Expression Systems Market Share by Region (2025-2030) Table 11. Eukaryotic Expression Systems Market Trends Table 12. Eukaryotic Expression Systems Market Drivers Table 13. Eukaryotic Expression Systems Market Challenges Table 14. Eukaryotic Expression Systems Market Restraints Table 15. Global Eukaryotic Expression Systems Revenue by Players (2019-2024) & (US$ Million) Table 16. Global Eukaryotic Expression Systems Revenue Share by Players (2019-2024) Table 17. Global Top Eukaryotic Expression Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eukaryotic Expression Systems as of 2023) Table 18. Global Eukaryotic Expression Systems Industry Ranking 2022 VS 2023 VS 2024 Table 19. Global 5 Largest Players Market Share by Eukaryotic Expression Systems Revenue (CR5 and HHI) & (2019-2024) Table 20. Global Key Players of Eukaryotic Expression Systems, Headquarters and Area Served Table 21. Global Key Players of Eukaryotic Expression Systems, Product and Application Table 22. Global Key Players of Eukaryotic Expression Systems, Product and Application Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Eukaryotic Expression Systems Market Size by Type (2019-2024) & (US$ Million) Table 25. Global Eukaryotic Expression Systems Revenue Market Share by Type (2019-2024) Table 26. Global Eukaryotic Expression Systems Forecasted Market Size by Type (2025-2030) & (US$ Million) Table 27. Global Eukaryotic Expression Systems Revenue Market Share by Type (2025-2030) Table 28. Global Eukaryotic Expression Systems Market Size by Application (2019-2024) & (US$ Million) Table 29. Global Eukaryotic Expression Systems Revenue Share by Application (2019-2024) Table 30. Global Eukaryotic Expression Systems Forecasted Market Size by Application (2025-2030) & (US$ Million) Table 31. Global Eukaryotic Expression Systems Revenue Share by Application (2025-2030) Table 32. North America Eukaryotic Expression Systems Market Size by Type (2019-2024) & (US$ Million) Table 33. North America Eukaryotic Expression Systems Market Size by Type (2025-2030) & (US$ Million) Table 34. North America Eukaryotic Expression Systems Market Size by Application (2019-2024) & (US$ Million) Table 35. North America Eukaryotic Expression Systems Market Size by Application (2025-2030) & (US$ Million) Table 36. North America Eukaryotic Expression Systems Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 37. North America Eukaryotic Expression Systems Market Size by Country (2019-2024) & (US$ Million) Table 38. North America Eukaryotic Expression Systems Market Size by Country (2025-2030) & (US$ Million) Table 39. Europe Eukaryotic Expression Systems Market Size by Type (2019-2024) & (US$ Million) Table 40. Europe Eukaryotic Expression Systems Market Size by Type (2025-2030) & (US$ Million) Table 41. Europe Eukaryotic Expression Systems Market Size by Application (2019-2024) & (US$ Million) Table 42. Europe Eukaryotic Expression Systems Market Size by Application (2025-2030) & (US$ Million) Table 43. Europe Eukaryotic Expression Systems Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 44. Europe Eukaryotic Expression Systems Market Size by Country (2019-2024) & (US$ Million) Table 45. Europe Eukaryotic Expression Systems Market Size by Country (2025-2030) & (US$ Million) Table 46. China Eukaryotic Expression Systems Market Size by Type (2019-2024) & (US$ Million) Table 47. China Eukaryotic Expression Systems Market Size by Type (2025-2030) & (US$ Million) Table 48. China Eukaryotic Expression Systems Market Size by Application (2019-2024) & (US$ Million) Table 49. China Eukaryotic Expression Systems Market Size by Application (2025-2030) & (US$ Million) Table 50. Asia Eukaryotic Expression Systems Market Size by Type (2019-2024) & (US$ Million) Table 51. Asia Eukaryotic Expression Systems Market Size by Type (2025-2030) & (US$ Million) Table 52. Asia Eukaryotic Expression Systems Market Size by Application (2019-2024) & (US$ Million) Table 53. Asia Eukaryotic Expression Systems Market Size by Application (2025-2030) & (US$ Million) Table 54. Asia Eukaryotic Expression Systems Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 55. Asia Eukaryotic Expression Systems Market Size by Region (2019-2024) & (US$ Million) Table 56. Asia Eukaryotic Expression Systems Market Size by Region (2025-2030) & (US$ Million) Table 57. Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Size by Type (2019-2024) & (US$ Million) Table 58. Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Size by Type (2025-2030) & (US$ Million) Table 59. Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Size by Application (2019-2024) & (US$ Million) Table 60. Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Size by Application (2025-2030) & (US$ Million) Table 61. Middle East, Africa, and Latin America Eukaryotic Expression Systems Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 62. Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Size by Country (2019-2024) & (US$ Million) Table 63. Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Size by Country (2025-2030) & (US$ Million) Table 64. Thermo Fisher Company Details Table 65. Thermo Fisher Business Overview Table 66. Thermo Fisher Eukaryotic Expression Systems Product Table 67. Thermo Fisher Revenue in Eukaryotic Expression Systems Business (2019-2024) & (US$ Million) Table 68. Thermo Fisher Recent Developments Table 69. Sigma Aldrich Company Details Table 70. Sigma Aldrich Business Overview Table 71. Sigma Aldrich Eukaryotic Expression Systems Product Table 72. Sigma Aldrich Revenue in Eukaryotic Expression Systems Business (2019-2024) & (US$ Million) Table 73. Sigma Aldrich Recent Developments Table 74. Jena Bioscience Company Details Table 75. Jena Bioscience Business Overview Table 76. Jena Bioscience Eukaryotic Expression Systems Product Table 77. Jena Bioscience Revenue in Eukaryotic Expression Systems Business (2019-2024) & (US$ Million) Table 78. Jena Bioscience Recent Developments Table 79. New England Biolabs Company Details Table 80. New England Biolabs Business Overview Table 81. New England Biolabs Eukaryotic Expression Systems Product Table 82. New England Biolabs Revenue in Eukaryotic Expression Systems Business (2019-2024) & (US$ Million) Table 83. New England Biolabs Recent Developments Table 84. Takara Bio Company Details Table 85. Takara Bio Business Overview Table 86. Takara Bio Eukaryotic Expression Systems Product Table 87. Takara Bio Revenue in Eukaryotic Expression Systems Business (2019-2024) & (US$ Million) Table 88. Takara Bio Recent Developments Table 89. Bio Rad Company Details Table 90. Bio Rad Business Overview Table 91. Bio Rad Eukaryotic Expression Systems Product Table 92. Bio Rad Revenue in Eukaryotic Expression Systems Business (2019-2024) & (US$ Million) Table 93. Bio Rad Recent Developments Table 94. Promega Company Details Table 95. Promega Business Overview Table 96. Promega Eukaryotic Expression Systems Product Table 97. Promega Revenue in Eukaryotic Expression Systems Business (2019-2024) & (US$ Million) Table 98. Promega Recent Developments Table 99. Agilent Company Details Table 100. Agilent Business Overview Table 101. Agilent Eukaryotic Expression Systems Product Table 102. Agilent Revenue in Eukaryotic Expression Systems Business (2019-2024) & (US$ Million) Table 103. Agilent Recent Developments Table 104. Merck Millipore Company Details Table 105. Merck Millipore Business Overview Table 106. Merck Millipore Eukaryotic Expression Systems Product Table 107. Merck Millipore Revenue in Eukaryotic Expression Systems Business (2019-2024) & (US$ Million) Table 108. Merck Millipore Recent Developments Table 109. Research Programs/Design for This Report Table 110. Key Data Information from Secondary Sources Table 111. Key Data Information from Primary Sources List of Figures Figure 1. Global Eukaryotic Expression Systems Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Figure 2. Global Eukaryotic Expression Systems Market Share by Type: 2023 VS 2030 Figure 3. Reagents Features Figure 4. Expression vectors Features Figure 5. Competent cells Features Figure 6. Global Eukaryotic Expression Systems Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) Figure 7. Global Eukaryotic Expression Systems Market Share by Application: 2023 VS 2030 Figure 8. Bacterial Expression System Case Studies Figure 9. Yeast Expression System Case Studies Figure 10. Insect Expression System Case Studies Figure 11. Mammalian Expression System Case Studies Figure 12. Eukaryotic Expression Systems Report Years Considered Figure 13. Global Eukaryotic Expression Systems Market Size (US$ Million), Year-over-Year: 2019-2030 Figure 14. Global Eukaryotic Expression Systems Market Size, (US$ Million), 2019 VS 2023 VS 2030 Figure 15. Global Eukaryotic Expression Systems Market Share by Region: 2023 VS 2030 Figure 16. Global Eukaryotic Expression Systems Market Share by Players in 2023 Figure 17. Global Top Eukaryotic Expression Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eukaryotic Expression Systems as of 2023) Figure 18. The Top 10 and 5 Players Market Share by Eukaryotic Expression Systems Revenue in 2023 Figure 19. North America Eukaryotic Expression Systems Market Size YoY Growth (2019-2030) & (US$ Million) Figure 20. North America Eukaryotic Expression Systems Market Share by Type (2019-2030) Figure 21. North America Eukaryotic Expression Systems Market Share by Application (2019-2030) Figure 22. North America Eukaryotic Expression Systems Market Share by Country (2019-2030) Figure 23. United States Eukaryotic Expression Systems Market Size YoY Growth (2019-2030) & (US$ Million) Figure 24. Canada Eukaryotic Expression Systems Market Size YoY Growth (2019-2030) & (US$ Million) Figure 25. Europe Eukaryotic Expression Systems Market Size YoY (2019-2030) & (US$ Million) Figure 26. Europe Eukaryotic Expression Systems Market Share by Type (2019-2030) Figure 27. Europe Eukaryotic Expression Systems Market Share by Application (2019-2030) Figure 28. Europe Eukaryotic Expression Systems Market Share by Country (2019-2030) Figure 29. Germany Eukaryotic Expression Systems Market Size YoY Growth (2019-2030) & (US$ Million) Figure 30. France Eukaryotic Expression Systems Market Size YoY Growth (2019-2030) & (US$ Million) Figure 31. U.K. Eukaryotic Expression Systems Market Size YoY Growth (2019-2030) & (US$ Million) Figure 32. Italy Eukaryotic Expression Systems Market Size YoY Growth (2019-2030) & (US$ Million) Figure 33. Russia Eukaryotic Expression Systems Market Size YoY Growth (2019-2030) & (US$ Million) Figure 34. Nordic Countries Eukaryotic Expression Systems Market Size YoY Growth (2019-2030) & (US$ Million) Figure 35. China Eukaryotic Expression Systems Market Size YoY (2019-2030) & (US$ Million) Figure 36. China Eukaryotic Expression Systems Market Share by Type (2019-2030) Figure 37. China Eukaryotic Expression Systems Market Share by Application (2019-2030) Figure 38. Asia Eukaryotic Expression Systems Market Size YoY (2019-2030) & (US$ Million) Figure 39. Asia Eukaryotic Expression Systems Market Share by Type (2019-2030) Figure 40. Asia Eukaryotic Expression Systems Market Share by Application (2019-2030) Figure 41. Asia Eukaryotic Expression Systems Market Share by Region (2019-2030) Figure 42. Japan Eukaryotic Expression Systems Market Size YoY Growth (2019-2030) & (US$ Million) Figure 43. South Korea Eukaryotic Expression Systems Market Size YoY Growth (2019-2030) & (US$ Million) Figure 44. China Taiwan Eukaryotic Expression Systems Market Size YoY Growth (2019-2030) & (US$ Million) Figure 45. Southeast Asia Eukaryotic Expression Systems Market Size YoY Growth (2019-2030) & (US$ Million) Figure 46. India Eukaryotic Expression Systems Market Size YoY Growth (2019-2030) & (US$ Million) Figure 47. Australia Eukaryotic Expression Systems Market Size YoY Growth (2019-2030) & (US$ Million) Figure 48. Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Size YoY (2019-2030) & (US$ Million) Figure 49. Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Share by Type (2019-2030) Figure 50. Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Share by Application (2019-2030) Figure 51. Middle East, Africa, and Latin America Eukaryotic Expression Systems Market Share by Country (2019-2030) Figure 52. Brazil Eukaryotic Expression Systems Market Size YoY Growth (2019-2030) & (US$ Million) Figure 53. Mexico Eukaryotic Expression Systems Market Size YoY Growth (2019-2030) & (US$ Million) Figure 54. Turkey Eukaryotic Expression Systems Market Size YoY Growth (2019-2030) & (US$ Million) Figure 55. Saudi Arabia Eukaryotic Expression Systems Market Size YoY Growth (2019-2030) & (US$ Million) Figure 56. Israel Eukaryotic Expression Systems Market Size YoY Growth (2019-2030) & (US$ Million) Figure 57. GCC Countries Eukaryotic Expression Systems Market Size YoY Growth (2019-2030) & (US$ Million) Figure 58. Thermo Fisher Revenue Growth Rate in Eukaryotic Expression Systems Business (2019-2024) Figure 59. Sigma Aldrich Revenue Growth Rate in Eukaryotic Expression Systems Business (2019-2024) Figure 60. Jena Bioscience Revenue Growth Rate in Eukaryotic Expression Systems Business (2019-2024) Figure 61. New England Biolabs Revenue Growth Rate in Eukaryotic Expression Systems Business (2019-2024) Figure 62. Takara Bio Revenue Growth Rate in Eukaryotic Expression Systems Business (2019-2024) Figure 63. Bio Rad Revenue Growth Rate in Eukaryotic Expression Systems Business (2019-2024) Figure 64. Promega Revenue Growth Rate in Eukaryotic Expression Systems Business (2019-2024) Figure 65. Agilent Revenue Growth Rate in Eukaryotic Expression Systems Business (2019-2024) Figure 66. Merck Millipore Revenue Growth Rate in Eukaryotic Expression Systems Business (2019-2024) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed
01. サンプル提供
ご購入前にサンプル(英語、日本語)が提供可能。
02. カスタマイズサービス
レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。
03. プロフェッショナルな日本語翻訳
AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。
04. 多言語コミュニケーション
日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。
05. お支払方法
銀行振込(納品後、ご請求書送付)。
06. アフターサービス
ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。
請求書払いの場合:
レポート選択
見積もり依頼
メールでのご注文
入手(英語版は2〜4営業日、日本語版は8〜10営業日)
決済(後払い)
クレジットカード決済の場合:
レポート選択
ウェブサイトでのご注文
決済
入手(英語版は2〜4営業日、日本語版は8〜10営業日)